vs
Pediatrix Medical Group, Inc.（MD）与Playtika Holding Corp.（PLTK）财务数据对比。点击上方公司名可切换其他公司
Playtika Holding Corp.的季度营收约是Pediatrix Medical Group, Inc.的1.4倍（$678.8M vs $493.8M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -45.6%，领先52.4%），Playtika Holding Corp.同比增速更快（4.4% vs -1.7%），过去两年Playtika Holding Corp.的营收复合增速更高（2.1% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Playtika Holding Corp是一家专注于移动端游戏开发与发行的以色列数字娱乐企业，主打休闲社交类手游产品，在全球拥有庞大用户群体。截至2021年，该公司月活跃用户规模已经突破3500万，是行业内影响力突出的移动游戏厂商。
MD vs PLTK — 直观对比
营收规模更大
PLTK
是对方的1.4倍
$493.8M
营收增速更快
PLTK
高出6.1%
-1.7%
净利率更高
MD
高出52.4%
-45.6%
两年增速更快
PLTK
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $678.8M |
| 净利润 | $33.7M | $-309.3M |
| 毛利率 | — | 72.5% |
| 营业利润率 | 9.9% | -41.4% |
| 净利率 | 6.8% | -45.6% |
| 营收同比 | -1.7% | 4.4% |
| 净利润同比 | 10.5% | -1752.1% |
| 每股收益（稀释后） | $0.40 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDPLTK
| Q4 25 | $493.8M | $678.8M | ||
| Q3 25 | $492.9M | $674.6M | ||
| Q2 25 | $468.8M | $696.0M | ||
| Q1 25 | $458.4M | $706.0M | ||
| Q4 24 | $502.4M | $650.3M | ||
| Q3 24 | $511.2M | $620.8M | ||
| Q2 24 | $504.3M | $627.0M | ||
| Q1 24 | $495.1M | $651.2M |
净利润MDPLTK
| Q4 25 | $33.7M | $-309.3M | ||
| Q3 25 | $71.7M | $39.1M | ||
| Q2 25 | $39.3M | $33.2M | ||
| Q1 25 | $20.7M | $30.6M | ||
| Q4 24 | $30.5M | $-16.7M | ||
| Q3 24 | $19.4M | $39.3M | ||
| Q2 24 | $-153.0M | $86.6M | ||
| Q1 24 | $4.0M | $53.0M |
毛利率MDPLTK
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.6% | ||
| Q2 25 | — | 71.9% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 72.5% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 72.8% |
营业利润率MDPLTK
| Q4 25 | 9.9% | -41.4% | ||
| Q3 25 | 13.8% | 14.6% | ||
| Q2 25 | 12.8% | 15.8% | ||
| Q1 25 | 7.0% | 9.6% | ||
| Q4 24 | 7.8% | 8.5% | ||
| Q3 24 | 6.6% | 15.7% | ||
| Q2 24 | -31.3% | 22.4% | ||
| Q1 24 | 3.2% | 15.1% |
净利率MDPLTK
| Q4 25 | 6.8% | -45.6% | ||
| Q3 25 | 14.5% | 5.8% | ||
| Q2 25 | 8.4% | 4.8% | ||
| Q1 25 | 4.5% | 4.3% | ||
| Q4 24 | 6.1% | -2.6% | ||
| Q3 24 | 3.8% | 6.3% | ||
| Q2 24 | -30.3% | 13.8% | ||
| Q1 24 | 0.8% | 8.1% |
每股收益（稀释后）MDPLTK
| Q4 25 | $0.40 | $-0.83 | ||
| Q3 25 | $0.84 | $0.11 | ||
| Q2 25 | $0.46 | $0.09 | ||
| Q1 25 | $0.24 | $0.08 | ||
| Q4 24 | $0.37 | $-0.04 | ||
| Q3 24 | $0.23 | $0.11 | ||
| Q2 24 | $-1.84 | $0.23 | ||
| Q1 24 | $0.05 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $684.2M |
| 总债务越低越好 | $570.5M | $2.4B |
| 股东权益账面价值 | $865.9M | $-411.4M |
| 总资产 | $2.2B | $3.7B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDPLTK
| Q4 25 | $375.2M | $684.2M | ||
| Q3 25 | $340.1M | $587.9M | ||
| Q2 25 | $224.7M | $500.9M | ||
| Q1 25 | $99.0M | $434.8M | ||
| Q4 24 | $229.9M | $565.8M | ||
| Q3 24 | $103.8M | $1.1B | ||
| Q2 24 | $19.4M | $710.3M | ||
| Q1 24 | $8.0M | $1.0B |
总债务MDPLTK
| Q4 25 | $570.5M | $2.4B | ||
| Q3 25 | $577.2M | $2.4B | ||
| Q2 25 | $583.9M | $2.4B | ||
| Q1 25 | $590.5M | $2.4B | ||
| Q4 24 | $597.1M | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B | ||
| Q1 24 | — | $2.4B |
股东权益MDPLTK
| Q4 25 | $865.9M | $-411.4M | ||
| Q3 25 | $890.7M | $-74.8M | ||
| Q2 25 | $833.8M | $-87.8M | ||
| Q1 25 | $789.2M | $-117.2M | ||
| Q4 24 | $764.9M | $-131.1M | ||
| Q3 24 | $732.5M | $-98.0M | ||
| Q2 24 | $706.5M | $-112.9M | ||
| Q1 24 | $856.2M | $-180.4M |
总资产MDPLTK
| Q4 25 | $2.2B | $3.7B | ||
| Q3 25 | $2.2B | $3.7B | ||
| Q2 25 | $2.1B | $3.6B | ||
| Q1 25 | $2.0B | $3.6B | ||
| Q4 24 | $2.2B | $3.6B | ||
| Q3 24 | $2.1B | $3.2B | ||
| Q2 24 | $2.0B | $3.2B | ||
| Q1 24 | $2.2B | $3.1B |
负债/权益比MDPLTK
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $285.9M |
| 自由现金流经营现金流 - 资本支出 | — | $275.2M |
| 自由现金流率自由现金流/营收 | — | 40.5% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 3.39× | — |
| 过去12个月自由现金流最近4个季度 | — | $531.4M |
8季度趋势，按日历期对齐
经营现金流MDPLTK
| Q4 25 | $114.1M | $285.9M | ||
| Q3 25 | $137.3M | $116.9M | ||
| Q2 25 | $137.2M | $146.1M | ||
| Q1 25 | $-117.5M | $18.8M | ||
| Q4 24 | $133.0M | $153.1M | ||
| Q3 24 | $91.8M | $156.9M | ||
| Q2 24 | $107.0M | $150.5M | ||
| Q1 24 | $-125.2M | $29.6M |
自由现金流MDPLTK
| Q4 25 | — | $275.2M | ||
| Q3 25 | — | $106.5M | ||
| Q2 25 | — | $141.3M | ||
| Q1 25 | — | $8.4M | ||
| Q4 24 | — | $140.3M | ||
| Q3 24 | — | $152.1M | ||
| Q2 24 | — | $141.2M | ||
| Q1 24 | — | $15.6M |
自由现金流率MDPLTK
| Q4 25 | — | 40.5% | ||
| Q3 25 | — | 15.8% | ||
| Q2 25 | — | 20.3% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 2.4% |
资本支出强度MDPLTK
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 2.1% |
现金转化率MDPLTK
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 2.99× | ||
| Q2 25 | 3.49× | 4.40× | ||
| Q1 25 | -5.66× | 0.61× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.99× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | -31.03× | 0.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PLTK
| Third Party Platform | $428.7M | 63% |
| Other | $158.8M | 23% |
| Asia Pacific | $52.7M | 8% |
| Other Geographic Location | $38.6M | 6% |
